Skip to main content

Advertisement

SpringerLink
Log in

Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases

  • Hepatobiliary and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Portal vein embolisation (PVE) can be used to increase the remnant liver parenchyma volume before major hepatectomy but may stimulate tumour growth. The pattern of disease recurrence and long-term survival has not been adequately addressed.

Methods

Over a period of 7 years 36 patients underwent preoperative PVE before resection of four or more liver segments for colorectal cancer (CRC) liver metastases. PVE was performed when the future liver remnant (FLR) assessed by magnetic resonance imaging (MRI) scan volumetry was less than 30%. Disease-free and overall survival was compared with a control group (65 patients) undergoing extended right/right hepatectomy for CRC metastases without PVE during the same time period.

Results

PVE was successful in all patients. PVE increased the median FLR volume by 37% [295 ml (22%) to 404 ml (32%), p < 0.0001]. 61% of patients undergoing PVE proceeded to liver resection (n = 22). Twelve patients (33%) developed disease progression following PVE. The 5-year survival after liver resection with PVE was 25%, compared with 50% without PVE. The 5-year disease-free survival was 30% post PVE and 50% without PVE.

Conclusion

We conclude that PVE significantly increases the future liver remnant. Only two-thirds of patients proceed to resection because of disease progression. Long-term survival is less than in patients who do not require PVE. The effect of PVE on tumour growth requires investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer. Br J Cancer. 2006;94(7):982–99.

    Article  PubMed  CAS  Google Scholar 

  2. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54(2):289–96.

    Article  PubMed  CAS  Google Scholar 

  3. Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: a 6-year retrospectivestudy of risk factors for perioperative mortality. J Am Coll Surg. 2001;192:47–53.

    Article  PubMed  CAS  Google Scholar 

  4. Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8.

    Article  PubMed  CAS  Google Scholar 

  5. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolizationto increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.

    PubMed  CAS  Google Scholar 

  6. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–6.

    Article  PubMed  CAS  Google Scholar 

  7. Elias D, De Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784–8.

    Article  PubMed  CAS  Google Scholar 

  8. Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, et al. One or two stage hepatectomy combined with portal vein embolisation for initially nonresectable colorectal liver metastases. Am J Surg. 2003;185(3):221–9.

    Article  PubMed  Google Scholar 

  9. Lindner P, Cahlin C, Friman S, Hafstrome L, Klingenstierna H, Lonn L, et al. Extended right sided liver resection for colorectal liver metastases-impact of percutaneous portal venous embolisation. Eur J Surg Oncol. 2006;32(3):292–6.

    Article  PubMed  CAS  Google Scholar 

  10. Beal I, Anthony S, Papadopoulou A, Huthins R, Fusai K, Begent R, et al. The effect of chemotherapy in patients undergoing portal vein embolisation prior to hepatic resection for colorectal liver metastases. Br J Radiol. 2006;79(942):473–8.

    Article  PubMed  CAS  Google Scholar 

  11. Bhattacharjya S, Aggarwal R, Davidson BR. Intense follow up after liver resection for colorectal metastases—results of combined serial tumor markers estimations and computed tomography of the chest and abdomen—a prospective study. Br J Cancer. 2006;95:21–6.

    Article  PubMed  CAS  Google Scholar 

  12. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94.

    Article  PubMed  CAS  Google Scholar 

  13. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery. 2008;143(4):476–82.

    Article  PubMed  Google Scholar 

  14. Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31(8):1643–51.

    Article  PubMed  Google Scholar 

  15. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94(3):274–86.

    Article  PubMed  CAS  Google Scholar 

  16. Hewes JC, Dighe S, Morris RW, Hutchins RR, Bhattacharya S, Davidson BR. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg. 2007;31(2):353–64.

    Article  PubMed  CAS  Google Scholar 

  17. Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med. 2007;48(5):685–92.

    Article  PubMed  Google Scholar 

  18. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008;15(7):1908–17.

    Article  PubMed  CAS  Google Scholar 

  19. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267–272.

    Article  PubMed  CAS  Google Scholar 

  20. Pamecha V, Levene A, Federica G, Dhillon A, Davidson BR. Effect of portal vein embolisation on tumor morphology of colorectal cancer liver metastases. HPB (Oxford). 2008;10(S1):227–8.

    Google Scholar 

  21. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240(6):1052–61; discussion 1061–4.

    Article  PubMed  Google Scholar 

  22. Wang X, Hershman DL, Abrams JA, Feingold D, Grann VR, Jacobson JS, et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer. 2007;97(12):1606–12.

    Article  PubMed  CAS  Google Scholar 

  23. Abdalla EK, Vauthey JN. Improved survival after resection of colorectal liver metastases. J Clin Oncol. 2006;24(17):2679.

    Article  PubMed  Google Scholar 

  24. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247(3):451–5.

    Article  PubMed  Google Scholar 

  25. Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10(3):365–70.

    Article  PubMed  Google Scholar 

  26. Zuckerman DS, Clark JW. Systemic therapy for metastatic colorectal cancer: current questions. Cancer. 2008;112(9):1879–91.

    Article  PubMed  CAS  Google Scholar 

  27. Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg. 2006;244(1):71–79.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepato-Pancreatico-Biliary and Liver Transplant Surgery, Royal Free Hospital and University College Medical School, University College London, London, NW3 2QG, UK

    Viniyendra Pamecha MS, MRCS, FEBS, Georgios Glantzounis, Giuseppe Fusai, Dinesh Sharma & Brian Davidson

  2. Department of Radiology, Royal Free Hospital and University College Medical School, University College London, London, NW3 2QG, UK

    Niel Davies

Authors
  1. Viniyendra Pamecha MS, MRCS, FEBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgios Glantzounis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Niel Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Fusai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dinesh Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Brian Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Viniyendra Pamecha MS, MRCS, FEBS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pamecha, V., Glantzounis, G., Davies, N. et al. Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases. Ann Surg Oncol 16, 1202–1207 (2009). https://doi.org/10.1245/s10434-008-0269-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0269-4

Keywords

Search

Navigation